Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Regenxbio (RGNX) over the last 11 years, with Q3 2025 value amounting to $42.3 million.

  • Regenxbio's Cash from Investing Activities fell 1586.02% to $42.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.1 million, marking a year-over-year decrease of 11351.87%. This contributed to the annual value of $103.4 million for FY2024, which is 4582.36% down from last year.
  • Latest data reveals that Regenxbio reported Cash from Investing Activities of $42.3 million as of Q3 2025, which was down 1586.02% from -$140.4 million recorded in Q2 2025.
  • Regenxbio's Cash from Investing Activities' 5-year high stood at $63.1 million during Q1 2023, with a 5-year trough of -$216.4 million in Q4 2021.
  • Over the past 5 years, Regenxbio's median Cash from Investing Activities value was $26.7 million (recorded in 2022), while the average stood at -$9.3 million.
  • Per our database at Business Quant, Regenxbio's Cash from Investing Activities skyrocketed by 520804.81% in 2023 and then plummeted by 5230149.25% in 2025.
  • Quarter analysis of 5 years shows Regenxbio's Cash from Investing Activities stood at -$216.4 million in 2021, then surged by 112.34% to $26.7 million in 2022, then increased by 27.24% to $34.0 million in 2023, then increased by 18.54% to $40.3 million in 2024, then rose by 5.0% to $42.3 million in 2025.
  • Its last three reported values are $42.3 million in Q3 2025, -$140.4 million for Q2 2025, and $44.7 million during Q1 2025.